Literature DB >> 2426171

Blood level of mitochondrial aspartate aminotransferase as an indicator of the extent of ischemic necrosis of the rat liver.

T Nishimura, Y Yoshida, F Watanabe, M Koseki, T Nishida, K Tagawa, Y Kawashima.   

Abstract

To assess the severity of ischemic liver injury, we examined release of mitochondrial aspartate aminotransferase (EC 2.6.1.1) and its cytoplasmic isozyme from the ischemic rat liver into the circulation. Their patterns of leakage were quite different: the level of cytoplasmic aspartate aminotransferase reached a peak soon after the circulation to the ischemic liver was restored, while that of mitochondrial aspartate aminotransferase increased slowly, reaching a maximum after more than 10 hr. On anoxic incubation of mitochondria isolated from the normal liver, oxidative phosphorylation capacity was lost within 2 hr, at which time no leakage of matrix enzymes was observed: more than 10 hr after-loss-of-oxidative phosphorylation were needed for the matrix enzymes to leak out of the mitochondrial membrane. Since the viability of cells is considered to depend on the capacity of oxidative phosphorylation, it is highly likely that the delayed appearance of mitochondrial aspartate aminotransferase in blood indicates the postmortem changes of injured cells. In fact, the cumulative activity of mitochondrial aspartate aminotransferase but not cytoplasmic aspartate aminotransferase in circulation after ischemic liver injury correlated fairly well with the decrease of total adenine nucleotides which were monitored to measure viable cells. The difference between mitochondrial aspartate aminotransferase and cytoplasmic aspartate aminotransferase as quantitative indices of hepatic necrosis may be due to the relative stability of the former and significant inactivation of the latter during hepatic ischemia. Therefore, the determination of mitochondrial aspartate aminotransferase in blood may be useful in the assessment of liver necrosis after ischemic injury.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2426171     DOI: 10.1002/hep.1840060427

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

1.  Non-cirrhotic liver tolerance to intermittent inflow occlusion during laparoscopic liver resection.

Authors:  Alberto Patriti; Cecilia Ceribelli; Graziano Ceccarelli; Alberto Bartoli; Raffaele Bellochi; Luciano Casciola
Journal:  Updates Surg       Date:  2012-03-06

2.  Histological and biochemical alterations in early-stage lobar ischemia-reperfusion in rat liver.

Authors:  Hossein-Ali Arab; Farhang Sasani; Mohammad-Hossein Rafiee; Ahmad Fatemi; Abbas Javaheri
Journal:  World J Gastroenterol       Date:  2009-04-28       Impact factor: 5.742

Review 3.  Clinical use of serum enzymes in liver disease.

Authors:  J J Reichling; M M Kaplan
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

4.  Branched-chain amino acid-enriched nutrients stimulate antioxidant DNA repair in a rat model of liver injury induced by carbon tetrachloride.

Authors:  Kengo Ichikawa; Takehiro Okabayashi; Yasuo Shima; Tatsuo Iiyama; Yuka Takezaki; Masaya Munekage; Tsutomu Namikawa; Takeki Sugimoto; Michiya Kobayashi; Toshiki Mimura; Kazuhiro Hanazaki
Journal:  Mol Biol Rep       Date:  2012-10-09       Impact factor: 2.316

5.  A multivariate analysis of the prognostic factors in severe liver trauma.

Authors:  T Nishida; N Fujita; K Nakao
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

6.  Effect of perioperative intensive insulin therapy for liver dysfunction after hepatic resection.

Authors:  Takehiro Okabayashi; Kengo Ichikawa; Tsutomu Namikawa; Takeki Sugimoto; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

7.  Leakage of cytoplasmic enzymes from rat heart by the stress of cardiac beating after increase in cell membrane fragility by anoxia.

Authors:  H Takami; H Matsuda; S Kuki; M Nishimura; Y Kawashima; H Watari; E Furuya; K Tagawa
Journal:  Pflugers Arch       Date:  1990-04       Impact factor: 3.657

8.  Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion.

Authors:  B Vollmar; J Glasz; R Leiderer; S Post; M D Menger
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

9.  Pentoxifylline inhibits liver expression of tumor necrosis factor alpha mRNA following normothermic ischemia-reperfusion.

Authors:  Alaa El-Ghoneimi; Raffaele Cursio; Annie Schmid-Alliana; Michel Tovey; Ahmed Lasfar; Jean-Francois Michiels; Bernard Rossi; Jean Gugenheim
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

10.  Prevention of Hepatic Ischemia-Reperfusion Injury by Carbohydrate-Derived Nanoantioxidants.

Authors:  Yin Long; Hao Wei; Jun Li; Mengting Li; Yizhan Wang; Ziyi Zhang; Tianye Cao; Corey Carlos; Lazarus G German; Dawei Jiang; Tuanwei Sun; Jonathan W Engle; Xiaoli Lan; Yadong Jiang; Weibo Cai; Xudong Wang
Journal:  Nano Lett       Date:  2020-08-14       Impact factor: 11.189

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.